Pharmaceutical Industry Articles & Reports - Page 45

Explore the digital therapeutics (DTx) market. This analysis covers market size, growth trends, key drivers, regulatory frameworks, and future outlook for 2025.

Learn about the EU AI Act's impact on pharma. Updated for 2026 with the Digital Omnibus proposal, GPAI Code of Practice, and revised Product Liability Directive. Includes risk classification, compliance steps, flowchart & SOP starter kit.

Explore 2025 data on AI adoption in U.S. hospitals. This report covers key statistics, use cases like sepsis detection, EHR integration, and adoption disparitie

An analysis of GLM-4.6 and its successor GLM-5, the leading open-source coding models. Compare benchmarks against Claude Opus 4.6, Sonnet 4.6, and GPT-5.3-Codex, plus hardware requirements

Explore a detailed cost-benefit analysis of RTSM implementation in clinical trials. Learn how RTSM systems reduce drug waste by 15-30%, save millions, and align with ICH E6(R3) and AI-driven forecasting trends in 2025-2026.

Learn how target trial emulation provides a structured framework for drawing causal inference from real-world evidence (RWE), with 2025 updates on the TARGET reporting guideline, ICH M14, and FDA guidance.

A 2026-updated technical comparison of Databricks vs. Snowflake for life sciences. Explore the lakehouse and AI data cloud for genomics, clinical data, Mosaic AI, Cortex AI, and ML workloads.

Our 2025 report analyzes the critical AI skills gap in the pharmaceutical industry, detailing the talent shortage with data and exploring key solutions.

An in-depth 2025 analysis of the leading medical imaging and digital pathology AI vendors. Covers market size, deep learning trends, and top company profiles.

An in-depth guide to IT system assessment in pharma M&A due diligence. Covers infrastructure, data, cybersecurity, AI governance, NIS2/CRA compliance, and FDA cybersecurity guidance for 2025-2026 deals.

Updated 2026 Epic vs Cerner AI comparison. Native AI Charting, CoMET foundation models, Oracle's next-gen EHR, Clinical AI Agent results, and the reshaping ambient scribe market.

Explore biotech salary trends across global regions, updated with 2024-2025 data. Compares pay in top hubs like the US, Switzerland, and Asia-Pacific with cost-of-living analysis and funding recovery trends.

Learn the GAMP 5 software categories for computerized system validation. This guide explains each category with examples, risk levels, and how they align with the 2025 ISPE GAMP AI Guide and FDA CSA framework.

A comprehensive guide to lab equipment qualification (IQ/OQ/PQ). Learn the process, regulatory standards including FDA's finalized CSA guidance, and how AI-powered automation streamlines validation and compliance.

Learn about Japan's PMDA regulatory pathways for drug approval under the PMD Act, including 2025 amendments. Covers standard and expedited options like Sakigake, Orphan Drug, and Conditional Approval

An in-depth review of Certara's drug development software suite for MIDD, updated for 2026. Covers Phoenix WinNonlin, Phoenix Cloud, the Simcyp PBPK Simulator, Certara IQ AI-powered QSP platform, and ICH M15 adoption.

Learn about Patient-Reported Outcomes (PRO) systems in clinical trials. This guide covers ePRO data collection, PROMs, FDA PFDD guidelines, CONSORT 2025 updates, AI-driven ePRO platforms, and challenges

Updated 2026 guide to AI-assisted surgery companies including Intuitive Surgical's da Vinci 5, Medtronic Hugo (FDA-cleared Dec 2025), CMR Versius Plus, Stryker Mako 4, and more. Market data, clinical outcomes, and regulatory trends.

Updated 2026 guide to ICH M7 mutagenic impurity assessment software including Derek Nexus 6.5, Sarah Nexus 5.1, Leadscope 2025.0, OECD QSAR Toolbox 4.8, AmesNet deep learning, and nitrosamine regulatory developments.

An in-depth study of pharmacy management systems updated for 2026. Explore key software features, compare top vendors (RedSail, Outcomes/TDS, Epic, Oracle Health), and learn about AI, DSCSA compliance, and market consolidation trends.

A detailed analysis of the global pharmaceutical market, forecast to reach $1.6T by 2025. Explore key growth drivers, therapy areas, and industry challenges.

An in-depth guide to ICH Q10 Pharmaceutical Quality Systems (PQS), updated for 2026 with ICH Q9(R1), Q12-Q14 developments, FDA QMM program updates, and AI-driven quality management trends.

An in-depth analysis of the ICH E6(R3) Good Clinical Practice guidelines for 2025. Explore key changes in Quality by Design, data governance, and decentralized

An overview of value-based contracting (VBC) in pharmaceuticals, where drug prices are tied to patient outcomes. Covers models, challenges, case studies, CMS CGT Access Model (2025), finalized VBP rule (2026), and IRA drug price negotiations.